aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Jun 18, 2015 · 10-Q · 79 days after period end · 0001193125-15-227340
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Net Income | -$9.07M | -$6.09M |
| EPS Diluted | -$9.39 | -$7.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed Jun 18, 2015 · 79 d after period end
